We are live on ! Find out more
XBIT icon

XBiotech

56 hedge funds and large institutions have $66.6M invested in XBiotech in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.97% less ownership

Funds ownership: 14.68%13.71% (-0.97%)

10% less capital invested

Capital invested by funds: $74M → $66.6M (-$7.38M)

14% less funds holding

Funds holding: 6556 (-9)

21% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 24

47% less call options, than puts

Call options by funds: $412K | Put options by funds: $780K

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
56
Holders Change
-9
Holders Change %
-13.85%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
19
Reduced
24
Closed
11
Calls
$412K
Puts
$780K
Net Calls
-$368K
Net Calls Change
+$677K

XBIT Hedge Fund Activity: Q2 2021 in Review

56 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2021, worth a combined $66.6M — down 10% from $74M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of XBIT and 2 opened new positions — a net loss of 9 holders — while 24 trimmed existing stakes and 19 added.

The largest buyer was Vanguard Group, adding an estimated $1.83M. The largest seller was BlackRock, cutting an estimated $2.65M.

  • 56 institutional investors held XBiotech (XBIT) as of Q2 2021, down from 65 in Q1 2021.
  • Funds reported $66.6M of XBiotech stock for Q2 2021, down 10% quarter-over-quarter.
  • 2 funds opened new XBiotech positions in Q2 2021 and 11 closed out, a net change of -9 holders.
  • The largest XBiotech buyer in Q2 2021 was Vanguard Group, an estimated $1.83M added.
  • The largest XBiotech seller in Q2 2021 was BlackRock, an estimated $2.65M sold.

Based on aggregated 13F filings for Q2 2021.